Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoproliferative Disorder (PTLD)

T-cell PTLDs are lymphoid proliferations that develop in recipients of SOT or allogeneic HSCT. They carry an extremely poor prognosis with a reported median survival of only 6 months. The infrequency with which they are encountered makes treatment a challenge due to the lack of prospective trials to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jennifer, Johnson, William T., Kartan, Saritha, Gonsalves, Anitha S., Fenkel, Jonathan M., Gong, Jerald Z., Porcu, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699839/
https://www.ncbi.nlm.nih.gov/pubmed/34940065
http://dx.doi.org/10.3390/curroncol28060426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699839/
https://www.ncbi.nlm.nih.gov/pubmed/34940065
http://dx.doi.org/10.3390/curroncol28060426

Ejemplares similares